Domagoj Mišković

Dr. Domagoj Mišković

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2019 in Acta Clinica Belgica
Verified
Journal Article
Closed access
IJIvana Jurin
Ivana Jurin
IHIrzal Hadžibegović
Irzal Hadžibegović
IDIvan Durlen
Ivan Durlen
SJSandra Jaksic Jurinjak
Sandra Jaksic Jurinjak
DMDomagoj Mišković
Domagoj Mišković
TLTomislav Letilović
Tomislav Letilović
Objective: Stratifying patients with paroxysmal or short-term persistent atrial fibrillation (AF) who are at greater risk of developing permanent AF is challenging. Aim of our prospective study was to evaluate association of laboratory parameters (biochemistry and complete blood count (CBC)) together with standard demographic, clinical and echocardiography parameters, with AF progression. Methods: We prospectively recruited 579 patients with AF and divided them into two groups at index hospitalization: paroxysmal or persistent (non-permanent AF), and long-term persistent or permanent AF patients (permanent AF). Clinical, echocardiographic, and relevant CBC parameters were collected. Non-permanent AF patients were selected for follow-up, with a median follow-up time of 21 months. Endpoint was progression to permanent AF. Results: Out of 409 patients with non-permanent AF, 109 (26.6%) progressed within follow-up. In a multivariate Cox regression model only increased left atrium (LA) diameter (HR 2.16, 95% CI 1.20–3.87, p = 0.010), and increased red cell distribution width (RDW; HR 1.19, 95% CI 1.03–1.39, p = 0.022) showed significant independent association with progression. There were 221/409 patients with both LA ≤45 mm and RDW level ≤14.5% who progressed at a rate of only 17.6%, and showed relative risk of AF progression of 0.47 (95% CI 0.34–0.67; p < 0,001). Conclusion: Together with LA size, RDW was independently associated with AF progression. Patients with both LA size ≤45 mm and RDW level ≤14.5% are most probably the best candidates for rhythm control strategies.

24 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IHIrzal Hadžibegović
Irzal Hadžibegović
IJIvana Jurin
Ivana Jurin
MKMihajlo Kovacic
Mihajlo Kovacic
TLTomislav Letilovic
Tomislav Letilovic
ALAnte Lisičić
Ante Lisičić
ŠMŠime Manola
Šime Manola
Background and aim: Patients with non-infarct-related artery chronic total occlusion (non-IRA CTO) found during percutaneous coronary intervention (PCI) in acute coronary syndromes (ACSs) are not rare and have worse clinical outcomes. We aimed to analyze their long-term clinical outcomes in regard to clinical characteristics, revascularization strategies, and adherence to medical therapy. Patients and methods: The dual-center ACS registry of patients treated from Jan 2017 to May 2023 was used to identify 1950 patients with timely PCI in ACS who survived to discharge with documented adequate demographic, clinical, and angiographic characteristics, treatment strategies, and medical therapy adherence during a median follow-up time of 49 months. Results: There were 171 (9%) patients with non-IRA CTO. In comparison to patients without non-IRA CTO, they were older, with more diabetes mellitus (DM), higher Syntax scores (median 27.5 vs. 11.5), and lower left ventricular ejection fraction (LVEF) at discharge (median LVEF 50% vs. 55%). There was also a lower proportion of patients with high adherence to medical therapy (32% vs. 46%). Patients with non-IRA CTO had significantly higher cardiovascular mortality during follow-up (18% vs. 8%, RR 1.87, 95% CI 1.27–2.75). After adjusting for relevant clinical and treatment characteristics in a multivariate Cox regression analysis, only lower LVEF, worse renal function, the presence of DM, and lower adherence to medical therapy were independently associated with higher cardiovascular mortality during follow-up, with low adherence to medical therapy as the strongest predictor (RR 3.18, 95% CI 1.76–5.75). Time to cardiovascular death was significantly lower in patients who did not receive non-IRA CTO revascularization, although CTO revascularization did not show independent association with survival in the multivariate analysis. Conclusions: Patients with non-IRA CTO found during ACS treatment have more unfavorable clinical characteristics, worse adherence to medical therapy, and higher cardiovascular mortality. They need a more scrutinized approach during follow-up to increase adherence to optimal medical therapy and to receive revascularization of the non-IRA CTO whenever it is clinically indicated and reasonably achievable without excess risks.

1 November 2023 in Cardiologia Croatica
Verified
Journal Article
Open access
EDEma Didović
Ema Didović
DMDomagoj Mišković
Domagoj Mišković
IBIvan Bitunjac
Ivan Bitunjac
DVDomagoj Vučić
Domagoj Vučić
KLKatica Cvitkušić Lukenda
Katica Cvitkušić Lukenda

1 November 2023 in Cardiologia Croatica
Verified
Journal Article
Open access
IČIvana Čičak
Ivana Čičak
KLKatica Cvitkušić Lukenda
Katica Cvitkušić Lukenda
DMDomagoj Mišković
Domagoj Mišković

1 November 2023 in Cardiologia Croatica
Verified
Journal Article
Closed access
KGKrešimir Gabaldo
Krešimir Gabaldo
TKTomislav Krčmar
Tomislav Krčmar
Marijana Knežević PravečekMarijana Knežević Praveček
Marijana Knežević Praveček
DMDomagoj Mišković
Domagoj Mišković
IBIvan Bitunjac
Ivan Bitunjac
KLKatica Cvitkušić Lukenda
Katica Cvitkušić Lukenda

1 November 2016 in Cardiologia Croatica
Verified
Journal Article
Closed access
DMDomagoj Mišković
Domagoj Mišković
IHIrzal Hadžibegović
Irzal Hadžibegović
BVBožo Vujeva
Božo Vujeva
Marijana Knežević PravečekMarijana Knežević Praveček
Marijana Knežević Praveček
ĐPĐeiti Prvulović
Đeiti Prvulović
MMMartina Menegoni
Martina Menegoni